Pfizer applies to FDA for approval of three-dose pediatric COVID-19 vaccine for children under five years of age.

Dr. Barry Dworkin

Medical Mythbusting Commentary for May 25, 2022

Pfizer applies to FDA for approval of three-dose pediatric COVID-19 vaccine for children under five years of age. Play Now | Play in Popup | Download

Source:
Pfizer says 3 COVID-19 shots protect children under 5

Related posts:

  1. Pfizer COVID-19 vaccine news is a press release not a study. No raw data to review, limited transparency, basic questions unanswered, 94 cases, and an overreaction focusing on the claim of 90% efficacy. Validated evidence required to justify the hype.
  2. Hope? Sure, but tone down the touting of experimental Pfizer drug to treat early Covid that hasn’t completed its 60-person phase 1 trial. And Miami private school ban on Covid-19-vaccinated teachers enters the pantheon of the Bizarro World.
  3. Pfizer to provide COVID vaccine trial data covering 5 to 11 year-olds to Health Canada for review and authorization. Company press releases are one thing but proper evaluation and scrutiny of the evidence is required.
  4. Phase 1 anti-cancer vaccine study shows great promise
Bitnami